Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Slupianek

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Oncogene|August 30, 2000
Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cellsM Nieborowska-Skorska, A Slupianek, T Skorski
Leukemia|August 7, 2009
BCR/ABL kinase interacts with and phosphorylates the RAD51 paralog, RAD51BA Slupianek, S K Jozwiakowski, E Gurdek, et al.
Biochimie|February 28, 2004
ABL-fusion oncoproteins activate multi-pathway of DNA repair: role in drug resistance?I Majsterek, A Slupianek, G Hoser, et al.
Annals of the New York Academy of Sciences|July 21, 1995
Interleukin-6-type cytokines affect glycosylation of acute phase proteins in vitroK Gryska, A Slupianek, M Laciak, et al.
Leukemia|April 11, 2008
BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stressM Koptyra, K Cramer, A Slupianek, et al.
Annals of the New York Academy of Sciences|July 21, 1995
Acute phase proteins and interleukin-6 serum levels in patients with chronic arterial occlusionW Majewski, R Staniszewski, A Slupianek, et al.
The Journal of Experimental Medicine|April 20, 1999
Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesisM Nieborowska-Skorska, M A Wasik, A Slupianek, et al.
Cancer Research|June 26, 1999
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of AktM Majewski, M Nieborowska-Skorska, P Salomoni, et al.
Oncogene|August 11, 2001
Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1Q Wang, H Zhang, S Guerrette, et al.
Molecular Cell|October 31, 2001
BCR/ABL regulates mammalian RecA homologs, resulting in drug resistanceA Slupianek, C Schmutte, G Tombline, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Oncogene|August 30, 2000
Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cellsM Nieborowska-Skorska, A Slupianek, T Skorski
Leukemia|August 7, 2009
BCR/ABL kinase interacts with and phosphorylates the RAD51 paralog, RAD51BA Slupianek, S K Jozwiakowski, E Gurdek, et al.
Biochimie|February 28, 2004
ABL-fusion oncoproteins activate multi-pathway of DNA repair: role in drug resistance?I Majsterek, A Slupianek, G Hoser, et al.
Annals of the New York Academy of Sciences|July 21, 1995
Interleukin-6-type cytokines affect glycosylation of acute phase proteins in vitroK Gryska, A Slupianek, M Laciak, et al.
Leukemia|April 11, 2008
BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stressM Koptyra, K Cramer, A Slupianek, et al.
Annals of the New York Academy of Sciences|July 21, 1995
Acute phase proteins and interleukin-6 serum levels in patients with chronic arterial occlusionW Majewski, R Staniszewski, A Slupianek, et al.
The Journal of Experimental Medicine|April 20, 1999
Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesisM Nieborowska-Skorska, M A Wasik, A Slupianek, et al.
Cancer Research|June 26, 1999
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of AktM Majewski, M Nieborowska-Skorska, P Salomoni, et al.
Oncogene|August 11, 2001
Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1Q Wang, H Zhang, S Guerrette, et al.
Molecular Cell|October 31, 2001
BCR/ABL regulates mammalian RecA homologs, resulting in drug resistanceA Slupianek, C Schmutte, G Tombline, et al.
Pageof 2